Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

This Week in R&D Pipeline News

Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Competitor Analysis.

Volume 4, Issue 34: Toll-like Receptor (TLR) Agonists

 

Target Pipeline:

Company Pipeline:

  • Telik (USA)

More Details inside R&D Pipeline News
Get your annual subscription and receive this issue for free!

R&D Pipeline News

Get your Subscription Now

R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.

  • The Technology Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week as a PDF directly to your desktop via e-mail.
  • The Therapeutic Area Edition lists the News in groups according to the Therapautic Area, e.g. oncology, neurology, etc
  • Or Get a 3-weeks free trial

 

Filter     Order     Display # 
Date Item Title
14 Aug 2006 R&D Pipeline News Vol. 2, Issue 31: mTOR Inhibitors
07 Aug 2006 R&D Pipeline News Vol. 2, Issue 30: VEGF Agonists, Poly (ADP-ribose) polymerase (PARP) Inhibitors and more
31 Jul 2006 R&D Pipeline News Vol. 2, Issue 29: SIP-R, IL-23/R, IL-13/R, GM-CSF/receptor, CD19 and more
03 Jul 2006 R&D Pipeline News Vol. 2, Issue 25: Updated Competitor Analysis G-CSF and GM-CSF
26 Jun 2006 R&D Pipeline News Vol. 2, Issue 24: Johnson & Johnson: full development pipeline
19 Jun 2006 R&D Pipeline News Vol. 2, Issue 23: Update on Thrombopoiesis Stimulating Agents
12 Jun 2006 R&D Pipeline News Vol. 2, Issue 22: News from ASCO 2006
02 Jun 2006 R&D Pipeline News Vol. 2, Issue 21: Update on Erythropoiesis-Stimulating Agents (ESA)
29 May 2006 R&D Pipeline News Vol. 2, Issue 20: Wyeth, Dong-A & ViroMed Pipelines
22 May 2006 R&D Pipeline News Vol. 2, Issue 19: PDE-4 Inhibitors
15 May 2006 R&D Pipeline News Vol. 2, Issue 18: Interferons
08 May 2006 R&D Pipeline News Vol. 2, Issue 17: Syk kinase Inhibitors
02 May 2006 R&D Pipeline News Vol. 2, Issue 16: Pipeline of adult allogeneic mesenchymal stem cells
25 Apr 2006 R&D Pipeline News Vol. 2, Issue 15: Small interfering RNA (siRNA or RNAi)
11 Apr 2006 R&D Pipeline News Vol. 2, Issue 14: Antibodies in Rheumatoid Arthritis
04 Apr 2006 R&D Pipeline News Vol. 2, Issue 13: Biologicals as VEGF and VEGF-R antagonists
28 Mar 2006 R&D Pipeline News Vol. 2, Issue 12: Inclu. Company profile Bayer Schering Pharma
21 Mar 2006 R&D Pipeline News Vol. 2, Issue 11: inclu. Anti-CD20 Antibody Pipeline
14 Mar 2006 R&D Pipeline News Vol. 2, Issue 10: inclu. Insulin Competitor Analysis
07 Mar 2006 R&D Pipeline News Vol. 2, Issue 09: inclu. IGF-1R antagonists
28 Feb 2006 R&D Pipeline News Vol. 2, Issue 08: inclu. Special Antibody Pipelines
21 Feb 2006 R&D Pipeline News Vol. 2, Issue 07: inclu. Cannabinoid-1 (CB1) receptor antagonists
14 Feb 2006 R&D Pipeline News Vol. 2, Issue 06: inclu. TOP 20 Biologics
07 Feb 2006 R&D Pipeline News Vol. 2, Issue 05: inclu. Glucagon-like peptide-1 (GLP-1) Analogs Pipeline
 
<< Start < Prev 1 2 3 Next > End >>
Results 101 - 124 of 124

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics